A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib
for Multiple Myeloma
Drug: Daratumumab
8 locations incl. Denver
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06892522·Phase 1, Phase 2·Recruiting